OriGene Technologies


OriGene Technologies was founded as a research tool company focused on the creation of the large commercial collection of full-length human cDNAs in a standard expression vector. The availability of the complete human genome sequence and the subsequent development of genome-based tools have enabled the identification of relevant drug targets through system biology approaches. OriGene's vision is to prepare comprehensive, genome wide research tools and technology platforms to enable scientists to study complete biological pathways, thus enabling a better understanding of disease mechanisms including cancer and stem cell research.

OriGene Technologies uses high-throughput, genome wide approach to develop products for pharmaceutical, biotechnology, and academic research. Our flagship product is the cDNA clone collection, a searchable gene bank of over 30,000 human full-length TrueClone cDNA collection and over 25,000 TrueORF cDNA clones. From our TrueORF cDNA clones, we have developed the broad offering of full length human proteins expressed in mammalian cells, ideal for functional studies. In 2010, OriGene initiated the TrueMAB™ project to develop mouse monoclonal antibodies against protein antigens with the goal to develop protein assays for every human protein.

In addition, OriGene offers unique gene expression products such as TissueScan cancer tissue qPCR arrays and tissue biorepository for biomarker discovery and validation

OriGene is committed to its mission to be “Your Gene Company”, in supplying everything a researcher needs for gene based research.

38,000 Human TrueClones Untagged full-length human cDNA clones
25,000 Mouse TrueClones Untagged full-length mouse cDNA clones
15,000 Rat TrueClones Untagged full-length rat cDNA clones
31,000 Human TrueORF Tagged human open reading frame cDNA clones
27,000 Mouse TrueORF Tagged mouse open reading frame cDNA clones
15,000 Rat TrueORF Tagged rat open reading frame cDNA clones
10,000 Human Protein Purified full length human proteins expressed in HEK293 cells
16,000 Transfected Lysates Over-expression cell lysates as antigens and assay standards
7,000 TrueMAB™ Antibodies High quality mouse monoclonal antibodies made against native protein epitopes for IHC, flow, IP ELISA applications
10,000 Primary Antibodies Validated primary antibodies targeting human proteins, including free positive controls.
200,000 HuSH-29 shRNA Pre-designed shRNA constructs targeting all human, mouse and rat genes


Inc 5000 Healthcare Company 2013-Tech-Fast-500-Deloitte.gif